Methods of Amplifying and Sequencing Nucleic Acids

Total Page:16

File Type:pdf, Size:1020Kb

Methods of Amplifying and Sequencing Nucleic Acids (19) & (11) EP 2 159 285 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 03.03.2010 Bulletin 2010/09 C12N 15/10 (2006.01) C12Q 1/68 (2006.01) (21) Application number: 09166658.6 (22) Date of filing: 28.01.2004 (84) Designated Contracting States: (72) Inventors: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR • Leamon, John H. HU IE IT LI LU MC NL PT RO SE SI SK TR Guilford, CT 06437 (US) Designated Extension States: • Lohman, Kenton AL LT LV MK Guilford, CT 06437 (US) • Rothberg, Jonathan M. (30) Priority: 29.01.2003 US 443471 P Guilford, CT 06437 (US) 23.04.2003 US 465071 P • Weiner, Michael P. 06.06.2003 US 476602 P Guilford, CT 06437 (US) 06.06.2003 US 476504 P 06.06.2003 US 476313 P (74) Representative: Aston, Heidi Frances 06.06.2003 US 476592 P Mintz, Levin, Cohn, Ferris, Glovsky and 25.08.2003 US 497985 P Popeo IP, LLP Alder Castle (62) Document number(s) of the earlier application(s) in 10 Noble Street accordance with Art. 76 EPC: London EC2V 7JX (GB) 04785758.6 / 1 590 477 Remarks: (71) Applicant: 454 Life Sciences Corporation This application was filed on 28-07-2009 as a Branford CT 06405 (US) divisional application to the application mentioned under INID code 62. (54) Methods of amplifying and sequencing nucleic acids (57) An apparatus and method for performing rapid DNA sequencing, such as genomic sequencing, is pro- vided herein. The method includes the steps of preparing a sample DNA for genomic sequencing, amplifying the prepared DNA in a representative manner, and perform- ing multiple sequencing reaction on the amplified DNA with only one primer hybridization step. EP 2 159 285 A2 Printed by Jouve, 75001 PARIS (FR) EP 2 159 285 A2 Description FIELD OF THE INVENTION 5 [0001] This invention relates to a method and apparatus for determining the base sequences of DNA. More particularly, this invention relates to methods and an apparatus with which the base sequences of a genome can be amplified and determined automatically or semiautomatically. BACKGROUND OF THE INVENTION 10 [0002] Development of rapid and sensitive nucleic acid sequencing methods utilizing automated DNA sequencers has revolutionized modem molecular biology. Analysis of entire genomes of plants, fungi, animals, bacteria, and viruses is now possible with a concerted effort by a series of machines and a team of technicians. However, the goal of rapid and automated or semiautomatic sequencing of a genome in a short time has not been possible. There continues to be 15 technical problems for accurate sample preparation, amplification and sequencing. [0003] One technical problem which hinders sequence analysis of genomes has been the inability of the investigator to rapidly prepare numerous nucleic acid sample encompassing a complete genome in a short period of time. [0004] Another technical problem is the inability to representatively amplified a genome to a level that is compatible with the sensitivity of current sequencing methods. Modem economically feasible sequencing machines, while sensitive, 20 still require in excess of one million copies of a DNA fragment for sequencing. Current methods for providing high copies of DNA sequencing involves variations of cloning or in vitro amplification which cannot amplify the number of individual clones (600,000 or more, and tens of millions for a human genome) necessary for sequencing a whole genome eco- nomically. [0005] Yet another technical problem in the limitation of current sequencing methods which can perform, at most, one 25 sequencing reaction per hybridization of oligonucleotide primer. The hybridization of sequencing primers is often the rate limiting step constricting the throughput of DNA sequencers. [0006] In most cases, Polymerase Chain Reaction (PCR; Saiki, R.K., et al., Science 1985, 230, 1350-1354; Mullis, K., et al., Cold Spring Harb. Symp. Quant. Biol. 1986, 51 Pt 1, 263-273) plays an integral part in obtaining DNA sequence information, amplifying minute amounts of specific DNA to obtain concentrations sufficient for sequencing. Yet, scaling 30 current PCR technology to meet the increasing demands of modem genetics is neither cost effective nor efficient, especially when the requirements for full genome sequencing are considered. [0007] Efforts to maximize time and cost efficiencies have typically focused on two areas: decreasing the reaction volume required for amplifications and increasing the number of simultaneous amplifications performed. Miniaturization confers the advantage of lowered sample and reagent utilization, decreased amplification times and increased throughput 35 scalability. [0008] While conventional thermocyclers require relatively long cycling times due to thermal mass restrictions (Woolley, A.T., et al., Anal. Chem. 1996, 68, 4081-4086), smaller reaction volumes can be cycled more rapidly. Continuous flow PCR devices have utilized etched microchannels in conjunction with fixed temperature zones to reduce reaction volumes to sub-microliter sample levels (Lagally, E.T., et al., Analytical Chemistry 2001, 73, 565-570; Schneegas, I., et al., Lab 40 on a Chip - The Royal Society of Chemistry 2001, 1, 42-49). [0009] Glass microcapillaries, heated by air (Kalinina, O., et al., Nucleic Acids Res. 1997, 25, 1999-2004) or infrared light (Oda, R.P., et al., Anal. Chem. 1998, 70, 4361-4368; Huhmer, A.F. and Landers, J.P., Anal. Chem. 2000, 72, 5507-5512), have also served as efficient vessels for nanoliter scale reactions. Similar reaction volumes have been attained with microfabricated silicon thermocyclers (Bums, M.A., et al., Proc. Natl. Acad. Sci. USA 1996, 93, 5556-5561). 45 [0010] In many cases, these miniaturizations have reduced total PCR reaction times to less than 30 minutes for modified electric heating elements (Kopp, M.U., et al., Science 1998, 280, 1046-1048; Chiou, J., Matsudaira, P., Sonin, A. and Ehrlich, D., Anal. Chem. 2001, 73, 2018-2021) and hot air cyclers (Kalinina, O., et al., Nucleic Acids Res. 1997, 25, 1999-2004), and to 240 seconds for some infrared controlled reactions (Giordano, B.C., et al., Anal. Biochem. 2001, 291, 124-132). 50 [0011] Certain technologies employ increased throughput and miniaturization simultaneously; as in the 1536-well system design by Sasaki et al. (Sasaki, N., et al., DNA Res. 1997, 4, 387-391), which maintained reaction volumes under 1 Pl. As another example, Nagai et al. (Nagai, H., et al., Biosens. Bioelectron. 2001, 16, 1015-1019; Nagai, H., et al., Anal. Chem. 2001, 73, 1043-1047) reported amplification of a single test fragment in ten thousand 86 pl reaction pits etched in a single silicon wafer. Unfortunately, recovery and utilization of the amplicon from these methods have 55 proven problematic, requiring evaporation through selectively permeable membranes. [0012] Despite these remarkable improvements in reactions volumes and cycle times, none of the previous strategies have provided the massively parallel amplification required to dramatically increase throughput to levels required for analysis of the entire human genome. DNA sequencers continue to be slower and more expensive than would be desired. 2 EP 2 159 285 A2 In the pure research setting it is perhaps acceptable if a sequencer is slow and expensive. But when it is desired to use DNA sequencers in a clinical diagnostic setting such inefficient sequencing methods are prohibitive even for a well financed institution.The large-scale parallel sequencing of thousands of clonally amplified targets would greatly facilitate large-scale, whole genome library analysis without the time consuming sample preparation process and expensive, 5 error-prone cloning processes. Successful high capacity, solid-phase, clonal DNA amplification can be used for numerous applications. Accordingly, it is clear that there exists a need for preparation of a genome or large template nucleic acids for sequencing, for amplification of the nucleic acid template, and for the sequencing of the amplified template nucleic acids without the constraint of one sequencing reaction per hybridization. Furthermore, there is a need for a system to connect these various technologies into a viable automatic or semiautomatic sequencing machine. 10 BRIEF SUMMARY OF THE INVENTION [0013] This invention describes an integrated system, comprising novel methods and novel apparatus for (1) nucleic acid sample preparation, (2) nucleic acid amplification, and (3) DNA sequencing. 15 [0014] The invention provides a novel method for preparing a library of multiple DNA sequences, particularly derived from large template DNA or whole (or partial) genome DNA. Sequences of single stranded DNA are prepared from a sample of large template DNA or whole or partial DNA genomes through fragmentation, polishing, adaptor ligation, nick repair, and isolation of single stranded DNA. The method provides for generating a ssDNA library linked to solid supports comprising: (a) generating a library of ssDNA templates; (b) attaching the ssDNA templates to solid supports; and (c) 20 isolating the solid supports on which one ssDNA template is attached. [0015] The invention also provides for a method of amplifying each individual member of a DNA library in a single reaction tube, by, e.g., encapsulating a plurality of DNA samples individually in a microcapsule of an emulsion, performing amplification of the plurality of encapsulated nucleic acid samples simultaneously, and releasing said amplified plurality of DNA from the microcapsules for subsequent reactions. In one embodiment, single copies of the nucleic acid template 25 species are hybridized to DNA capture beads, suspended in complete amplification solution and emulsified into micro- reactors (typically 100 to 200 microns in diameter), after which amplification (e.g., PCR) is used to clonally increase copy number of the initial template species to more than 1,000,000 copies of a single nucleic acid sequence, preferably between 2 and 20 million copies of a single nucleic acid. The amplification reaction, for example, may be performed simultaneously with at least 3,000 microreactors per microliter of reaction mix, and may be performed with over 300,000 30 microreactors in a single 100Pl volume test tube (e.g., a PCR reaction tube).
Recommended publications
  • Wo 2007/086935 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date PCT (10) International Publication Number 2 August 2007 (02.08.2007) WO 2007/086935 A2 (51) International Patent Classification: Not classified (US). MYERS, Eugene, W. [-/US]; 20 Commercial Street, Branford, CT 06405 (US). SIMPSON, John, (21) International Application Number: W. [US/US]; 23 Woodland Road, Suite B4, Madison, PCT/US2006/030235 CT 06443 (US). VOLKMER, Greg, A. [-/US]; 20 Commercial Street, Branford, CT 06405 (US). (22) International Filing Date: 1 August 2006 (01.08.2006) (74) Agent: HOPKINS, Brian, P.; Mintz, Levin, Cohn, Ferris, (25) Filing Language: English Glovsky And Popeo, Rc, Chrysler Center, 666 Third Av enue, New York, NY 10017 (US). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of national protection available): AE, AG, AL, AM, 11/195,254 1 August 2005 (01.08.2005) US AT,AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, (71) Applicant (for all designated States except US): 454 LIFE GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, SCIENCES CORPORATION [US/US]; 20 Commercial KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, Street, Branford, CT 06405 (US). LU, LV,LY,MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, (72) Inventors; and SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, (75) Inventors/Applicants (for US only): MCDADE, Keith, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW E.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,557,518 B2 Jovanovich Et Al
    US008557518B2 (12) United States Patent (10) Patent No.: US 8,557,518 B2 Jovanovich et al. (45) Date of Patent: Oct. 15, 2013 (54) MCROFLUDIC AND NANOFLUIDC (56) References Cited DEVICES, SYSTEMS, AND APPLICATIONS U.S. PATENT DOCUMENTS (75) Inventors: Stevan Bogdan Jovanovich, Livermore, 3,190,310 A 6/1965 Honsinger CA (US); Iuliu I. Blaga, Fremont, CA 11/1967 Ando et al. (US); Michael Nguyen, San Jose, CA 3,352,643 A (US); William D. Nielsen, San Jose, CA (Continued) (US); Mattias Vangbo, Fremont, CA (US) FOREIGN PATENT DOCUMENTS CA 2433145 A1 5, 2002 (73) Assignee: IntegenX Inc., Pleasanton, CA (US) EP O459.241 B1 12, 1991 (*) Notice: Subject to any disclaimer, the term of this (Continued) patent is extended or adjusted under 35 OTHER PUBLICATIONS U.S.C. 154(b) by 109 days. Shaikh et all “A modular microfluidic archetecture for integrated (21) Appl. No.: 12/845,650 biochemical analysis”, PNAS, 2005, 102: 9745-9750.* (22) Filed: Jul. 28, 2010 (Continued) (65) Prior Publication Data Primary Examiner — Betty Forman US 2012/O1151.89 A1 May 10, 2012 (57) ABSTRACT Related U.S. Application Data The present invention discloses the integration of program (63) Continuation of application No. 12/526,015, filed as mable microfluidic circuits to achieve practical applications application No. PCT/US2008/053099 on Feb. 5, 2008. to process biochemical and chemical reactions and to inte grate these reactions. In some embodiments workflows for (60) Provisional application No. 60/899,630, filed on Feb. biochemical reactions or chemical workflows are combined. 5, 2007. Microvalves such as programmable microfluidic circuit with Y valves and flow through valves are disclosed.
    [Show full text]
  • Genetic Sequence Analysis by Microarray Technology EMILIE HULTIN
    Genetic Sequence Analysis by Microarray Technology EMILIE HULTIN Royal Institute of Technology School of Biotechnology Stockholm 2007 © Emilie Hultin Royal Institute of Technology AlbaNova University Center School of Biotechnology SE-106 91 Stockholm Sweden Printed at Universitetsservice US-AB Box 700 14 SE-100 44 Stockholm Sweden ISBN 978-91-7178-609-8 Emilie Hultin (2007): Genetic Sequence Analysis by Microarray Technology School of Biotechnology, Royal Institute of Technology (KTH), Stockholm, Sweden ISBN 978-91-7178-609-8 Abstract Developments within the field of genetic analysis have during the last decade become enormous. Advances in DNA sequencing technology have increased throughput from a thousand bases to over a billion bases in a day and decreased the cost thousandfold per base. Nevertheless, to sequence complex genomes like the human is still very expensive and efforts to attain even higher throughputs for less money are undertaken by researchers and companies. Genotyping systems for single nucleotide polymorphism (SNP) analysis with whole genome coverage have also been developed, with low cost per SNP. There is, however, a need for genotyping assays that are more cost efficient per sample with considerably higher accuracy. This thesis is focusing on a technology, based on competitive allele- specific extension and microarray detection, for genetic analysis. To increase specificity in allele-specific extension (ASE), a nucleotide degrading enzyme, apyrase, was introduced to compete with the polymerase, only allowing the fast, perfect matched primer extension to occur. The aim was to develop a method for analysis of around twenty loci in hundreds of samples in a high-throughput microarray format.
    [Show full text]
  • Resolution of DNA Mixtures and Analysis of Degraded DNA Using the 454 DNA Sequencing Technology
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Resolution of DNA Mixtures and Analysis of Degraded DNA Using the 454 DNA Sequencing Technology Author(s): Cassandra D. Calloway, Ph.D., Hanna Kim, Henry Erlich Document No.: 249100 Date Received: August 2015 Award Number: 2010-DN-BX-K141 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this federally funded grant report available electronically. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Resolution of DNA Mixtures and Analysis of Degraded DNA Using the 454 DNA Sequencing Technology Grant #:2010-DN-BX-K141 Principal Investigator Cassandra D. Calloway, PhD Authors Cassandra D. Calloway, PhD, Hanna Kim, and Henry Erlich This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. I. Abstract The massively parallel and clonal nature of next generation sequencing (NGS) technologies has the potential to revolutionize the forensics DNA field. NGS is capable of analyzing sequence polymorphisms (e.g. mtDNA, SNPs) as well as length polymorphisms (e.g. STRs) on the same platform. Moreover, sequencing STR markers will detect any sequence polymorphisms in the STR loci, thus increasing the discrimination potential of these widely used markers.
    [Show full text]
  • Bio 215 Course Title: General Biochemistry Laboratory I
    NATIONAL OPEN UNIVERSITY OF NIGERIA SCHOOL OF SCIENCE AND TECHNOLOGY COURSE CODE: BIO 215 COURSE TITLE: GENERAL BIOCHEMISTRY LABORATORY I 1 BIO 215: GENERAL BIOCHEMISTRY LABORATORY I Course Developer: DR (MRS.) AKIN-OSANAIYE BUKOLA CATHERINE UNIVERISTY OF ABUJA Course Editor: Dr Ahmadu Anthony Programme Leader: Professor A. Adebanjo Course Coordinator: Adams Abiodun E. 2 UNIT 1 INTRODUCTION TO LABORATORY AND LABORATORY EQUIPMENT CONTENTS 1.0 Introduction 2.0 Objectives 3.0 Main Body 3.1 What is a Laboratory? 3.2 Laboratory Equipment 4.0 Conclusion 5.0 Summary 6.0 Tutor-marked Assignments 7.0 References/Further Readings 1.0 INTRODUCTION Scientific research and investigations will be of little value without good field and laboratory work. These investigations are normally carried out through the active use of processes which involves laboratory or other hands-on activities. Many devices and products used in everyday life resulted from laboratory works. They include car engines, plastics, radios, televisions, synthetic fabrics, etc. 3 2.0 OBJECTIVES Upon completion of studying this unit, you should be able to: 1. Define the meaning of laboratory 2. List different types of laboratories 3. Identify different types of laboratory equipment 3.0 MAIN BODY 3.1 What is a Laboratory? A laboratory informally, lab is a facility that provides controlled conditions in which scientific research, experiments, and measurement may be performed. It is a place equipped for investigative procedures and for the preparation of reagents, therapeutic chemical materials, and so on. The title of laboratory is also used for certain other facilities where the processes or equipment used are similar to those in scientific laboratories.
    [Show full text]
  • 1455189355674.Pdf
    THE STORYTeller’S THESAURUS FANTASY, HISTORY, AND HORROR JAMES M. WARD AND ANNE K. BROWN Cover by: Peter Bradley LEGAL PAGE: Every effort has been made not to make use of proprietary or copyrighted materi- al. Any mention of actual commercial products in this book does not constitute an endorsement. www.trolllord.com www.chenaultandgraypublishing.com Email:[email protected] Printed in U.S.A © 2013 Chenault & Gray Publishing, LLC. All Rights Reserved. Storyteller’s Thesaurus Trademark of Cheanult & Gray Publishing. All Rights Reserved. Chenault & Gray Publishing, Troll Lord Games logos are Trademark of Chenault & Gray Publishing. All Rights Reserved. TABLE OF CONTENTS THE STORYTeller’S THESAURUS 1 FANTASY, HISTORY, AND HORROR 1 JAMES M. WARD AND ANNE K. BROWN 1 INTRODUCTION 8 WHAT MAKES THIS BOOK DIFFERENT 8 THE STORYTeller’s RESPONSIBILITY: RESEARCH 9 WHAT THIS BOOK DOES NOT CONTAIN 9 A WHISPER OF ENCOURAGEMENT 10 CHAPTER 1: CHARACTER BUILDING 11 GENDER 11 AGE 11 PHYSICAL AttRIBUTES 11 SIZE AND BODY TYPE 11 FACIAL FEATURES 12 HAIR 13 SPECIES 13 PERSONALITY 14 PHOBIAS 15 OCCUPATIONS 17 ADVENTURERS 17 CIVILIANS 18 ORGANIZATIONS 21 CHAPTER 2: CLOTHING 22 STYLES OF DRESS 22 CLOTHING PIECES 22 CLOTHING CONSTRUCTION 24 CHAPTER 3: ARCHITECTURE AND PROPERTY 25 ARCHITECTURAL STYLES AND ELEMENTS 25 BUILDING MATERIALS 26 PROPERTY TYPES 26 SPECIALTY ANATOMY 29 CHAPTER 4: FURNISHINGS 30 CHAPTER 5: EQUIPMENT AND TOOLS 31 ADVENTurer’S GEAR 31 GENERAL EQUIPMENT AND TOOLS 31 2 THE STORYTeller’s Thesaurus KITCHEN EQUIPMENT 35 LINENS 36 MUSICAL INSTRUMENTS
    [Show full text]
  • Next-Generation DNA Sequencing Techniques Review
    New Biotechnology Volume 25, Number 4 April 2009 REVIEW Next-generation DNA sequencing techniques Review Wilhelm J. Ansorge Ecole Polytechnique Federal Lausanne, EPFL, Switzerland Next-generation high-throughput DNA sequencing techniques are opening fascinating opportunities in the life sciences. Novel fields and applications in biology and medicine are becoming a reality, beyond the genomic sequencing which was original development goal and application. Serving as examples are: personal genomics with detailed analysis of individual genome stretches; precise analysis of RNA transcripts for gene expression, surpassing and replacing in several respects analysis by various microarray platforms, for instance in reliable and precise quantification of transcripts and as a tool for identification and analysis of DNA regions interacting with regulatory proteins in functional regulation of gene expression. The next-generation sequencing technologies offer novel and rapid ways for genome-wide characterisation and profiling of mRNAs, small RNAs, transcription factor regions, structure of chromatin and DNA methylation patterns, microbiology and metagenomics. In this article, development of commercial sequencing devices is reviewed and some European contributions to the field are mentioned. Presently commercially available very high-throughput DNA sequencing platforms, as well as techniques under development, are described and their applications in bio-medical fields discussed. Introduction Sanger method was used in the first automated fluorescent project Next-generation high-throughput DNA sequencing techniques, for sequencing of a genome region, in which sequence determina- which are opening fascinating new opportunities in biomedicine, tion of the complete gene locus for the HPRT gene was performed were selected by Nature Methods as the method of the year in 2007 using the EMBL technique; in that project the important concept of [1].
    [Show full text]
  • Laboratory Glassware
    This week we are launching Wikivoyage . Join us in creating a free travel guide that anyone can edit. Laboratory glassware From Wikipedia, the free encyclopedia Jump to: navigation, search This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (February 2011) Three beakers, an Erlenmeyer flask, a graduated cylinder and a volumetric flask Brown glass jars with some clear lab glassware in the background Laboratory glassware refers to a variety of equipment, traditionally made of glass, used for scientific experiments and other work in science, especially in chemistry and biology laboratories. Some of the equipment is now made of plastic for cost, ruggedness, and convenience reasons, but glass is still used for some applications because it is relatively inert, transparent, more heat-resistant than some plastics up to a point, and relatively easy to customize. Borosilicate glasses are often used because they are less subject to thermal stress and are common for reagent bottles. For some applications quartz glass is used for its ability to withstand high temperatures or its transparency in certain parts of the electromagnetic spectrum. In other applications, especially some storage bottles, darkened brown or amber (actinic) glass is used to keep out much of the UV and IR radiation so that the effect of light on the contents is minimized. Special-purpose materials are also used; for example, hydrofluoric acid is stored and used in polyethylene containers because it reacts with glass.[1] For pressurized reaction, heavy-wall glass is used for pressure reactor.
    [Show full text]
  • Synthesis of Sequence-Verified Nucleic Acids Synthese Von Nukleinsäuren Mit Verifizierter Sequenz Synthèse D’Acides Nucléiques À Séquence Vérifiée
    (19) TZZ ¥__T (11) EP 2 398 915 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12Q 1/68 (2006.01) C12N 15/10 (2006.01) 24.08.2016 Bulletin 2016/34 (86) International application number: (21) Application number: 10705856.2 PCT/EP2010/052140 (22) Date of filing: 19.02.2010 (87) International publication number: WO 2010/094772 (26.08.2010 Gazette 2010/34) (54) SYNTHESIS OF SEQUENCE-VERIFIED NUCLEIC ACIDS SYNTHESE VON NUKLEINSÄUREN MIT VERIFIZIERTER SEQUENZ SYNTHÈSE D’ACIDES NUCLÉIQUES À SÉQUENCE VÉRIFIÉE (84) Designated Contracting States: (56) References cited: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR WO-A2-2008/022789 HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR • CALVET J P: "MOLECULAR APPROACHES FOR ANALYZING DIFFERENTIAL GENE (30) Priority: 20.02.2009 US 154091 P EXPRESSION: DIFFERENTIAL CDNA LIBRARY CONSTRUCTION AND SCREENING" PEDIATRIC (43) Date of publication of application: NEPHROLOGY, SPRINGER VERLAG, BERLIN, 28.12.2011 Bulletin 2011/52 DE LNKD- DOI:10.1007/BF00857891, vol. 5, no. 6, 1 January 1991 (1991-01-01) , pages 751-757, (73) Proprietor: Synthetic Genomics, Inc. XP008018106 ISSN: 0931-041X La Jolla, CA 92037 (US) • DROEGE M ET AL: "The Genome Sequencer FLX(TM) System-Longer reads, more (72) Inventors: applications, straight forward bioinformatics and • STÄHLER, Peer F. more complete data sets" JOURNAL OF 68167 Mannheim (DE) BIOTECHNOLOGY, ELSEVIER SCIENCE • CARAPITO, Raphaël PUBLISHERS, AMSTERDAM, NL LNKD- F-67100 Strasbourg (FR) DOI:10.1016/J.JBIOTEC.2008.03.021, vol.
    [Show full text]
  • Effects of Nitrogen-Fixing Symbiotic Cyanobacteria on the Microbial Ecology of the Coral, Montastraea Cavernosa
    University of New Hampshire University of New Hampshire Scholars' Repository Doctoral Dissertations Student Scholarship Spring 2012 Effects of nitrogen-fixing symbiotic cyanobacteria on the microbial ecology of the coral, Montastraea cavernosa Jessica K. Jarett University of New Hampshire, Durham Follow this and additional works at: https://scholars.unh.edu/dissertation Recommended Citation Jarett, Jessica K., "Effects of nitrogen-fixing symbiotic cyanobacteria on the microbial ecology of the coral, Montastraea cavernosa" (2012). Doctoral Dissertations. 652. https://scholars.unh.edu/dissertation/652 This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. EFFECTS OF NITROGEN-FIXING SYMBIOTIC CYANOBACTERIA ON THE MICROBIAL ECOLOGY OF THE CORAL, MONTASTRAEA CAVERNOSA BY JESSICA KJARETT BS, Southampton College, 2005 DISSERTATION Submitted to the University of New Hampshire in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Microbiology May, 2012 UMI Number: 3525060 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. OiSi«Wior» Ftattlisttlfl UMI 3525060 Published by ProQuest LLC 2012. Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved.
    [Show full text]
  • Dna Mutation/Methylation Screening Method for Colon Cancer Screening
    DNA MUTATION/METHYLATION SCREENING METHOD FOR COLON CANCER SCREENING WEI MENG Bachelor of Science in Chemical Engineering Zhengzhou University July, 2003 Submitted in partial fulfillment of requirements for the degree DOCTOR OF PHILOSOPHY IN CLINICAL/BIOANALYTICAL CHEMISTRY at CLEVELAND STATE UNIVERSITY November, 2010 This dissertation has been approved for the Department of Chemistry and for the College of Graduate Studies of Cleveland State University By __________________________________________________ Date______________ Dr. Baochuan Guo, Dept of Chemistry/Cleveland State University Major Advisor __________________________________________________ Date______________ Dr. Aimin Zhou, Dept of Chemistry/Cleveland State University Advisory committee Member __________________________________________________ Date______________ Dr. Anton Komar, Dept of BGES/Cleveland State University Advisory committee Member __________________________________________________ Date______________ Dr. John Masnovi, Dept of Chemistry/Cleveland State University Advisory committee Member __________________________________________________ Date______________ Dr. Stan Duraj, Dept of Chemistry/Cleveland State University Advisory committee Member ACKNOWLEDGMENTS First of all, I would like to thank my advisor, Dr. Baochuan Guo, Ph.D, Professor of Chemistry, Cleveland State University for his guidance. During five years of study, he encouraged me and led me into a new research field which I haven’t touched before. My scientific training was benefited from his unforgettable support and kind management. Members of Dr.Guo’s research group are quite friendly and supportive. I used to be an engineering majored student and was lack of biochemistry knowledge. The group members spend plenty of time to train me when I stepped into the lab. The lab members, including Xiyuan Sun, Xiangzhu Xiao, Yiding Liu, Xiaopeng Li and Xiaohan Cai, provided me their important experience and discussion on my several projects.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,323,305 B2 Leamon Et Al
    USOO73233 05B2 (12) United States Patent (10) Patent No.: US 7,323,305 B2 LeamOn et al. (45) Date of Patent: Jan. 29, 2008 (54) METHODS OF AMPLFYING AND (52) U.S. Cl. ............................. 435/6; 435/8; 435/91.2: SEQUENCING NUCLEIC ACIDS 435/91.52; 435/175; 435/287.2:435/288.7; 536/24.2:536/24.33 (75) Inventors: John H. Leamon, Guilford, CT (US); (58) Field of Classification Search ..................... None Kenton L. Lohman, Guilford, CT See application file for complete search history. (US); Jonathan M. Rothberg, Guilford, CT (US); Michael P. Weiner, (56) References Cited Guilford, CT (US) U.S. PATENT DOCUMENTS (73) Assignee: 454 Life Sciences Corporation, 4,683, 195 A 7, 1987 Mullis et al. Branford, CT (US) (*) Notice: Subject to any disclaimer, the term of this (Continued) patent is extended or adjusted under 35 FOREIGN PATENT DOCUMENTS U.S.C. 154(b) by 289 days. EP O 373 203 8, 1994 (21) Appl. No.: 10/767,779 (22) Filed: Sep. 22, 2004 (Continued) (65) Prior Publication Data OTHER PUBLICATIONS US 2005/O 130173 A1 Jun. 16, 2005 Nakano et al. Single-molecule PCR using water-in-oil emulsion. J Biotechnol. Apr. 24, 2003; 102(2): 117-24.* Related U.S. Application Data (60) Provisional application No. 60/497,985, filed on Aug. (Continued) 25, 2003, provisional application No. 60/476,313, Primary Examiner Young J. Kim filed on Jun. 6, 2003, provisional application No. Assistant Examiner Samuel Woolwine 60/476,504, filed on Jun. 6, 2003, provisional appli (74) Attorney, Agent, or Firm—Ivor R.
    [Show full text]